SourceWire: Medical and Pharmaceutical https://pressreleases.responsesource.com Mon, 12 Jun 2023 10:24:04 +0100 hello@responsesource.com (ResponseSource Press Release Wire) support@responsesource.com Copyright2023 ResponseSource Ltd. https://static.responsesource.com/favicon.ico <![CDATA[ResponseSource Press Release Wire: Medical and Pharmaceutical]]> https://pressreleases.responsesource.com Zend Framework Zend_Feed en-us http://blogs.law.harvard.edu/tech/rss 60 https://www.responsesource.com/news/104136/accelerating-the-discovery-of-new-treatments-for-neurological-disorders-through/ <![CDATA[Accelerating the discovery of new treatments for neurological disorders through Open Science]]> https://feeds.feedblitz.com/~/745599794/0/sourcewiremedicalandpharmaceutical~Accelerating-the-discovery-of-new-treatments-for-neurological-disorders-through-Open-Science/ https://www.responsesource.com/news/104136/accelerating-the-discovery-of-new-treatments-for-neurological-disorders-through/       ]]>

The Neuro (Montreal Neurological Institute-Hospital), a leading neuroscience research centre and hospital, is participating in the Global Health Initiative 2023 campaign led by TBD Media Group in support of the World Health Organization. The documentary series aims to galvanize health care leaders, scientists, policy makers, industry, pharma, and members of the general public to ensure the health of the global community.

The Neuro was selected as the representative for neurological disorders and highlights the need for Open Science - transparent, borderless global science - to find effective treatments for neurological disorders.

Global burden of neurological disorders:
Neurological disorders such as stroke, dementia, migraine, and epilepsy are collectively the leading global source of disability
The World Health Organization estimates that one billion people are affected by neurological disorders
9 million die every year from these illnesses
An aging population makes this an immediate and pressing challenge
By 2030, one in six people in the world will be aged 60 years or over

To meet the global public health challenge of neurological disorders, The Neuro has radically transformed its approach to brain science. As the first university institute in the world to fully embrace Open Science, The Neuro is sharing resources and expertise, and has been pioneering open tools and infrastructure to share research data and biological samples with the global research community.

“The Neuro is committed to improving the lives of patients with neurological disorders and advancing science and medicine to resolve the debilitating and destructive global burden of neurological diseases,” says Dr. Guy Rouleau, Director of The Neuro.

The Neuro has created the world’s first and only combined Open Science biobank and patient registry devoted to neurological diseases. It includes imaging, clinical, demographic, genetic, cellular and neuro-psychiatric data, as well as biological samples from more than 3,000 de-identified participants.

Partnering with patients and their families in The Neuro’s Open Biobank is enabling the global research community to tackle the significant burden of brain diseases facing us all today. “As someone living with Amyotrophic Lateral Sclerosis (ALS), I have decided to donate my patient data and biological samples to The Neuro’s Open Biobank, says Kris Noakes, patient advocate. “It’s inspiring to be a part of something where globally people are collaborating in this manner. There is real momentum and it's wonderful to be part of something new and hopeful for patients with neurological disorders.”

About The Neuro (Montreal Neurological Institute-Hospital):
The Neuro is a bilingual, world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, The Neuro has grown to be the largest specialized neuroscience research and clinical center in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world’s top minds make The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders. In 2016, The Neuro became the first university institute in the world to fully embrace the Open Science philosophy, creating the Tanenbaum Open Science Institute. The Montreal Neurological Institute is a McGill University research and teaching institute. The Montreal Neurological Hospital is part of the Neuroscience Mission of the McGill University Health Centre.

About TBD Media Group:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Mon, 12 Jun 2023 10:10:00 +0100 https://www.responsesource.com/news/104105/equality-and-the-future-of-pandemic-prevention-kncv-tb-plus/ <![CDATA[Equality and The Future of Pandemic Prevention: KNCV TB Plus Develops Innovative Technologies to Prevent Infections In Developing Nations.]]> https://feeds.feedblitz.com/~/744701264/0/sourcewiremedicalandpharmaceutical~Equality-and-The-Future-of-Pandemic-Prevention-KNCV-TB-Plus-Develops-Innovative-Technologies-to-Prevent-Infections-In-Developing-Nations/ https://www.responsesource.com/news/104105/equality-and-the-future-of-pandemic-prevention-kncv-tb-plus/       ]]>
Tuberculosis (TB) is the second most infectious killer after Covid-19 mostly impacting lower economic countries, with 1.5 million people dying from this infection every year (World Health Organisation). KNCV TB Plus (KNCV) has developed cutting edge technologies which detect early stages of TB infection eliminating the risks of spread within many communities. This diversifies the access to healthcare within poor communities and ultimately saves many lives. KNCV has teamed up with TBD Media Group taking part in their Global Health campaign. Here they promote global health equality featuring documentaries from different countries highlighting prominent issues within healthcare.

Using their experts and highly specialised data planning KNCV aims towards a future free of TB and other related diseases. The company's groundbreaking achievements have propelled TB awareness to the forefront of global initiatives with many of their experts being based in the Hague. Executive Director of KNCV, Gidado Mustapha, has advocated for, and treated many who suffer with TB and believes that “we are obliged to prevent this pandemic from continuing.”
To learn more about KNCV TB Plus and to watch the interview, click here: www.kncvtbc.org & https://www.reuters.com/plus/tbd-media-group/connect-people-...

About KNCV TB Plus
KNCV TB Plus is an organisation determined to eradicate TB and other related diseases by using their resources and experts to target lower socio economic areas. They are continuously developing and enhancing new solutions to combat TB. By utilising technology KNCV develops new drugs and treatments putting their patients at the heart of their operations.

About TBD Media:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/

Media contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Wed, 07 Jun 2023 09:05:00 +0100 https://www.responsesource.com/news/104095/luminova-pharma-group-illuminating-the-future-of-life-changing-medicines/ <![CDATA[Luminova Pharma Group: Illuminating the Future of Life-Changing Medicines]]> https://feeds.feedblitz.com/~/743930408/0/sourcewiremedicalandpharmaceutical~Luminova-Pharma-Group-Illuminating-the-Future-of-LifeChanging-Medicines/ https://www.responsesource.com/news/104095/luminova-pharma-group-illuminating-the-future-of-life-changing-medicines/       ]]>
Luminova Pharma Group, a groundbreaking pharmaceutical company, is poised to revolutionise the healthcare landscape with its innovative approach to developing life-changing medicines. Luminova Pharma Group is a part of the TBD Media Group Global Health campaign, which strives to raise awareness and share knowledge about technological advancements and the dedication to ensuring that everyone has access to high-quality healthcare, regardless of country or social class.

As the number of individuals with diabetes and other medical conditions is increasing rapidly in Central, The Caribbean and South America, Luminova recognises the importance of collaboration, by actively seeking partnerships with academic institutions, biotechnology companies, and government organisations such as The Foundation Aldo Castañeda.

They also maintain a broad portfolio which includes an array of therapies and medicines. Through their ingenuity they have developed a band of many different treatments. These include Unipharm therapy: which treats acute symptoms, Uninova: elevating chronic diseases, Uninutra: providing vitamins and supplements and; Novum providing access to a variety of treatments.

The convergence of expertise between Mike Erichsen, esteemed President of Luminova Pharma Group, and the distinguished Dr Gonzalo Calvimontes, Vice President of Foundation Aldo Castañeda, forges an awe-inspiring endeavour.

Reaching over seven different South American countries, Luminova Pharma Group provides healthcare for countless individuals (We are in 14 countries in Central America, The Caribbean and South America). Promoting a vision to provide first class healthcare to the masses regardless of socio economic status; they continue to defy expectations by maximising their resources to save innumerable lives.

At the heart of their mission lies a profound dedication to elevating the lives of patients afflicted by congenital heart disease. Fueled by an unwavering commitment, their collective vision transcends boundaries, leveraging a specialised medical team and cutting-edge technology to both amass essential funds and deliver exceptional care to those in need.

For more information on Luminova, click here: https://www.luminovapg.com/
To watch Luminova Global Health film , click here: https://www.reuters.com/plus/tbd-media-group/connect-people-...

About Luminova Pharma:
Luminova Pharma is a visionary pharmaceutical company dedicated to transforming patients' lives through innovative, life-changing medicines. With a strong focus on precision medicine and patient-centricity, Luminova Pharma uses cutting-edge research and cutting-edge technology to develop targeted therapies for the most challenging diseases.

About TBD Media Group:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media Contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Fri, 02 Jun 2023 09:05:00 +0100 https://www.responsesource.com/news/104103/medscape-to-feature-in-the-global-health-campaign/ <![CDATA[Medscape to Feature in the Global Health Campaign]]> https://feeds.feedblitz.com/~/743792567/0/sourcewiremedicalandpharmaceutical~Medscape-to-Feature-in-the-Global-Health-Campaign/ https://www.responsesource.com/news/104103/medscape-to-feature-in-the-global-health-campaign/       ]]>
“We are very proud to be part of the Global Health campaign as it promises to spotlight some of the true innovators in healthcare from around the world,” said Jeremy Schneider, Senior Vice President and Group General Manager, WebMD Global.

Medscape provides robust medical news, clinical information, expert perspectives, and professional educational tools to a vast number of more than 6.5 million physicians and 11 million healthcare professionals worldwide, across 33 medical specialties.

“Healthcare professionals face a substantial challenge in staying up-to-date with clinical developments that have a direct impact on patient care. We are very proud of the role Medscape plays in helping physicians around the world make informed treatment decisions that can lead to better patient outcomes,” said Schneider.

For more than 27 years, Medscape has been a facilitator of change in the healthcare industry. As a part of their mission, Medscape is continuing to explore the limitless possibilities of AI and develop new and personalized collaborative tools for clinicians.


About Medscape
Medscape is the leading source of clinical news, health information, and point-of-care tools for health care professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programs for physicians, nurses, and other health care professionals.
Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company.

About WebMD Health Corp.
WebMD Health Corp., an Internet Brands Company, is the leading provider of health information services, serving patients, physicians, health care professionals, employers, and health plans through our public and private online portals, mobile platforms, and health- focused publications. The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, prIME Oncology, MediQuality, Frontline, QxMD, Vitals Consumer Services, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org®, and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.

SOURCE Medscape

About TBD Media:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media Contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Thu, 01 Jun 2023 09:05:00 +0100 https://www.responsesource.com/news/104101/the-search-is-on-for-a-brilliant-cancer-research-student/ <![CDATA[The Search is on for a Brilliant Cancer Research Student to Win a Bursary Worth up to £12,000]]> https://feeds.feedblitz.com/~/743661521/0/sourcewiremedicalandpharmaceutical~The-Search-is-on-for-a-Brilliant-Cancer-Research-Student-to-Win-a-Bursary-Worth-up-to-%c2%a3/ https://www.responsesource.com/news/104101/the-search-is-on-for-a-brilliant-cancer-research-student/       ]]>
Red Trouser Day, a UK bowel/colorectal cancer charity, run by volunteers, has put out the call to postgraduate research students. Paul Finch, founder of the charity, says, "It is only through research that we can improve the treatment of cancer, and hopefully one day, see the elimination of this disease. Few know that bowel cancer is the third most common cancer worldwide, and the second most common cause of cancer fatalities, leading to almost one million deaths per year. Our award is open to all postgraduate students whose research can impact bowel cancer outcomes."

The Red Trouser Day charity, founded in 2017, is run solely by volunteers. Many of these fundraisers have had their lives affected by bowel cancer. Paul speaks on behalf of all the volunteers, "We know that an exceptional student is out there in one of the UK's excellent universities. Only by going public with this search, will this substantial bursary help a well-deserving student with their research into bowel cancer."

Everyone involved with the Red Trouser Day charity is aware that finding funding for postgraduate research is becoming increasingly difficult. Nationwide cutbacks affect everyone, including students; this is why they have prioritised this award. 95% of all the Red Trouser Day funds raised,(excluding event costs), goes to sponsor research and awareness. Paul stresses that funding is one of the most common difficulties facing postgraduate students, "Just one student, free from financial constraints, could have a major effect on fighting cancer. That talented person, with the freedom to fully focus on developing new solutions, could potentially lead to new insights."

Last year's Red Trouser Day award allowed an exceptional research student from City, the University of London, to focus solely on her work. She had been holding down two part-time jobs just to pay for her living expenses, until the Red Trouser Day charity stepped in with a bursary.

The year’s award will go to a student whose research work shows promise in furthering the understanding of bowel cancer and contributes to preventing, improving the early detection of, or improving the treatment of colorectal cancer, aligning with the charity’s goals.

So we encourage everyone to get the word out there, that the search is now on!

In addition, there are two further discretionary awards available to help students. There is a travel award of £500, for undergraduate and postgraduate students researching cancer worldwide. This bursary can be used to fund travel to conferences, seminars, or for visits to the UK to further bowel cancer research. A final award of up to £1,000 will be available for funding research consumables.

The closing date for all applications is August 31, 2023.

Contact & Further Information:

To contact the Red Trouser Day Press Office, please email: info@redtrouserday.com

Full details of our bursaries, terms & conditions, and an application form, can be found on our website: https://redtrouserday.com/
      
]]> Wed, 31 May 2023 13:30:00 +0100 https://www.responsesource.com/news/104094/unleashing-the-symphony-of-sound-med-el-s-revolutionary-breakthroughs-redefine-the/ <![CDATA[Unleashing the Symphony of Sound: MED-EL's Revolutionary Breakthroughs Redefine the Future of Hearing]]> https://feeds.feedblitz.com/~/743661725/0/sourcewiremedicalandpharmaceutical~Unleashing-the-Symphony-of-Sound-MEDELs-Revolutionary-Breakthroughs-Redefine-the-Future-of-Hearing/ https://www.responsesource.com/news/104094/unleashing-the-symphony-of-sound-med-el-s-revolutionary-breakthroughs-redefine-the/       ]]>
MED-EL has consistently pushed the boundaries of what is possible in the field of hearing implant technology to bring the gift of hearing to people globally. Through extensive research, development, and collaboration with leading experts, MED-EL has developed a comprehensive range of implantable devices and rehabilitation solutions that cater to a wide spectrum of hearing needs, and is continuing to make hearing care accessible to all through the use of robotics, AI, and telemedicine, as well as international development programmes for hospitals in low income countries.

The company's participation in this global health campaign reinforces its position as a trailblazer in the field of hearing healthcare and technology.With a strong commitment to innovation, accessibility, and the well-being of individuals, MED-EL continues to lead the way in transforming the lives of those with hearing loss.

The main contents of the film includes interviews with Dr Ingeborg Hochmair, (Co-founder and CTO), Dr Patrick D’Haese (Director of Public Affairs) and Max who is an engineer, Hearpeers mentor and user of cochlear implants.

Find out more about MED-EL: https://www.medel.com/
To watch MED-EL film, click here: https://www.reuters.com/plus/tbd-media-group/connect-people-...

About MED-EL:
MED-EL is a leading provider of hearing implant solutions, with a mission to overcome hearing loss as a barrier to communication. With over 40 years of experience in the field, MED-EL offers innovative hearing solutions that restore hearing and transform lives. MED-EL's products include cochlear implants, middle ear implants, and bone conduction implants, all designed with the goal of delivering the best possible hearing outcomes for individuals of all ages.

About TBD Media:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media Contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Wed, 31 May 2023 13:05:00 +0100 https://www.responsesource.com/news/104090/siemens-healthineers-showcases-innovations-in-cancer-therapy-access-to-care/ <![CDATA[Siemens Healthineers showcases innovations in cancer therapy, access to care and workforce challenges]]> https://feeds.feedblitz.com/~/743639819/0/sourcewiremedicalandpharmaceutical~Siemens-Healthineers-showcases-innovations-in-cancer-therapy-access-to-care-and-workforce-challenges/ https://www.responsesource.com/news/104090/siemens-healthineers-showcases-innovations-in-cancer-therapy-access-to-care/       ]]>
The rapid pace of development in healthcare is constantly producing new innovations that push the boundaries of what is possible. Siemens Healthineers has an outstanding combination of expertise and experience to understand these changes and shape the future of healthcare. The company focuses on three key themes: Personalisation of Care, Operational Excellence and Intelligently Connected Systems of Care.

Siemens Healthineers' latest keynote, delivered to a global audience of leading physicians, healthcare executives and industry experts, focused on breakthroughs in cancer treatment. While cancer remains one of the leading causes of death worldwide, Siemens Healthineers has made significant advances in personalised medicine. Scalable technologies and AI-powered clinical decision support can improve prognosis and enable preventive measures.

The healthcare system faces the challenge of providing effective care to a growing number of people. Siemens Healthineers will present innovative solutions to address this challenge in the keynote. Through the use of technology and operational excellence, more stress-free working environments can be created for healthcare staff to increase care efficiency and better meet the needs of patients.

A key focus of the keynote will be on addressing the healthcare workforce crisis. The shortage of skilled workers and the increasing demand for qualified professionals pose major challenges for the healthcare system. Siemens Healthineers will present innovative approaches to address this crisis. Through the use of technology and operational excellence, more stress-free work environments can be created, allowing healthcare workers more time for patient care.

Siemens Healthineers wants to make these groundbreaking ideas and innovations accessible to a wide audience. The inspiring film presenting the keynote highlights is now available on the renowned Reuters platform. Learn how Siemens Healthineers is revolutionising cancer care and helping people live healthier lives.

This inspiring film offers fascinating insights into these innovations and shows how Siemens Healthineers is helping people lead healthier lives. Learn more about revolutionary cancer treatments and the advances made possible thanks to the pioneering work of Siemens Healthineers. To view the film, please visit: https://www.reuters.com/plus/tbd-media-group/connect-people-...

This article provides only a snapshot of the topics addressed in the Siemens Healthineers Shape Keynote 23. For the full keynote presentation and more information, please visit: [https://events.siemens-healthineers.com/shape-keynote].


Media Contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Wed, 31 May 2023 09:05:00 +0100 https://www.responsesource.com/news/104096/for-healthcare-the-only-future-is-remote-patient-monitoring-here/ <![CDATA[For Healthcare, the Only Future is Remote Patient Monitoring. Here’s How Untitled Kingdom Leads the Way]]> https://feeds.feedblitz.com/~/743640344/0/sourcewiremedicalandpharmaceutical~For-Healthcare-the-Only-Future-is-Remote-Patient-Monitoring-Here%e2%80%99s-How-Untitled-Kingdom-Leads-the-Way/ https://www.responsesource.com/news/104096/for-healthcare-the-only-future-is-remote-patient-monitoring-here/       ]]>
So when TBD Media Group launched its Global Health campaign featuring documentaries from all over the world with the main theme being “Health for All,” we were looking for not just the voice of technological innovation but of equality and inclusivity too. And we found that voice in Untitled Kingdom - a Polish HealthTech product and software development company.

Untitled Kingdom works with patient-driven companies to develop medical solutions that reflect the vision of where technology is supporting care delivery and access. Their documentary speaks on the importance and impact of remote patient solutions. These solutions refer to technology that patients can use at home to perform self-testing, self-examination, and health status surveillance. Devices that improve access to health screenings and diagnosis and therefore help achieve healthcare’s primary goal: disease prevention. And Untitled Kingdom is one of the top HealthTech companies co-developing remote patient monitoring software and technology.

‘Equality starts with technology’ said Piotr Zajac, CEO of Untitled Kingdom. “And to me, it means that regardless of your geography, socio-economic background, sexual identity, or financial status, technology facilitates equal opportunities and enables us to be whoever we want to be. In the case of HealthTech, it provides access to reliable care.”

And Untitled Kingdom proved itself a successful HealthTech and MedTech organization by creating relatable solutions across the healthcare industry, including Eargo and Elvie Pump. More than 75 released digital products for the healthcare sector and medical educational programs for developers, designers, and quality testers. This company is a unique place where tech experts become MedTech specialists – bridging the world of medicine and technology.

To learn more about Untitled Kingdom, click here: www.untitledkingdom.com and https://www.reuters.com/plus/tbd-media-group/connect-people-...

About Untitled Kingdom
Untitled Kingdom specializes in bringing exceptional digital health and MedTech solutions to life. What’s more, this team of specialists works exclusively on projects that improve the health and lives of users. Offering software and product development services to provide effective and safe healthcare. Overcoming social barriers through coding and cutting-edge technology.

About TBD Media Group:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media Contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Tue, 30 May 2023 09:00:00 +0100 https://www.responsesource.com/news/104081/falck-pioneers-sustainable-healthcare-solutions-for-future-needs/ <![CDATA[Falck pioneers sustainable healthcare solutions for future needs]]> https://feeds.feedblitz.com/~/742862342/0/sourcewiremedicalandpharmaceutical~Falck-pioneers-sustainable-healthcare-solutions-for-future-needs/ https://www.responsesource.com/news/104081/falck-pioneers-sustainable-healthcare-solutions-for-future-needs/       ]]>
In our fast-paced and ever-evolving world, healthcare systems worldwide are facing an array of challenges and mounting pressures. The world's growing population, along with rising average age and an increasing number of people living with chronic diseases, has created an urgent demand for healthcare and treatment like never before and the demand for healthcare services exceeds the available and equitable healthcare workers.

Falck is driving remarkable innovations that not only transform the health sector but also reduce pressure on healthcare systems by preventing hospital admissions though new preventive healthcare solutions which deliver more healthcare with fewer resources.

“As a global healthcare company, we work as a close partner to different healthcare systems around the world. Even though the systems are different, they all face the same challenges with an increasing demand for healthcare and not enough healthcare workers to meet the demand. It’s crucial that we change the way we look at healthcare and become better at preempting hospital admissions and advance healthcare technologies which provide the necessary help, but with fewer resources,” says CEO at Falck, Jakob Riis.

For instance, in Colombia, Falck managed to transition 40% of the 1.5 million annual physical consultations to online medical care. This approach not only brings healthcare to isolated areas, it also reduces carbon footprint and maximises the utilisation of healthcare workers.

Falck keeps exploring the huge potential in advancing solutions that prevent health situations from becoming acute, such as monitoring solutions for the elderly or multi-chronic patients to spot fluctuations of vital parameters. This will ensure that the necessary care is provided before a situation evolves and becomes acute – saving the patient an unnecessary ambulance trip and releasing pressure on both pre-hospital services and hospitals.

Health drones
Another example of advancing healthcare in remote areas is using health drones for transporting blood samples or critical medication between settlements and hospitals for a faster diagnosis and treatment that potentially prevents long-term or serious illness.

The technology is already there, just waiting to be utilised

To find out more about Falck, click here https://www.falck.com/
To watch Falck’s film as a part of the Global Health campaign, click here


About Falck:
Falck is a global emergency response and healthcare services company headquartered in Denmark. With a rich history dating back to 1906, Falck has evolved into a leading provider of emergency medical services and healthcare solutions in Europe, US and Latin America.

About TBD Media Group
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media Contact:
Supprija Sanmuganathan
Marketing Coordinator
TBD Media Group
s.sanmuganathan@tbdmediagroup.com
      
]]> Fri, 26 May 2023 15:45:00 +0100 https://www.responsesource.com/news/104079/leading-experts-reshaping-healthcare-industry/ <![CDATA[Leading Experts Reshaping Healthcare Industry]]> https://feeds.feedblitz.com/~/742819844/0/sourcewiremedicalandpharmaceutical~Leading-Experts-Reshaping-Healthcare-Industry/ https://www.responsesource.com/news/104079/leading-experts-reshaping-healthcare-industry/       ]]>
The Global Health campaign will highlight some of the most groundbreaking work being done by leaders in the healthcare field, showcasing the latest technologies, research, and strategies being used to improve health outcomes and advance healthcare delivery. The campaign will also explore the critical role that healthcare plays in economic development, social justice, and global security.

"We believe that the development of the healthcare sector is crucial to the well-being of people all over the world," said Paolo Zanini, CEO of TBD Media Group. "Through our Global Health campaign, we hope to shine a spotlight on the incredible work being done by innovative leaders in this field, and to inspire others to take action and make a difference in the world."

The Global Health campaign will feature a series of interviews, articles, and videos with leading healthcare experts, including doctors, researchers, policymakers, and entrepreneurs. These experts will showcase specific health initiatives, developing ground-breaking medicine and complex health technologies, whilst taking on the challenges of both physical and mental health worldwide.

"We are thrilled to bring attention to the incredible work being done by healthcare leaders around the world," said Zanini. "Through the Global Health campaign, we hope to inspire others to join us in the fight for a healthier, more equitable world."

The Global Health campaign is just one of the many initiatives launched by TBD Media Group in its commitment to promoting innovation, development, and social responsibility. With a focus on cutting-edge technology, digital advancement, and thought leadership, TBD Media Group is dedicated to making a positive impact on society and the world.

Companies featured in this launch:
Erbe: Untitled Kingdom: University of Freiburg: ViiV Healthcare: Falck: MED-EL: Siemens Healthineers: Bupa: Luminova Pharma Group: Klafs: The Neuro (Montreal Neurological Institute-Hospital): Tobii Dynavox: WHOOP: Emma Sleep: Wicker Gruppe: KNCV: Avance Clinical: Medscape

To learn more about TBD Media Group's Global Health campaign and to watch the video documentaries and interviews, click here : https://www.reuters.com/plus/tbd-media-group/connect-people-...

About TBD Media Group:
TBD Media Group is an international, purpose-driven media developer that helps businesses, organisations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/


Media Contact:
Aishat Okunade
Marketing Coordinator
TBD Media Group
a.okunade@tbdmediagroup.com
      
]]> Fri, 26 May 2023 09:45:00 +0100 https://www.responsesource.com/news/104072/healthcare-recruitment-woes-continue/ <![CDATA[Healthcare recruitment woes continue]]> https://feeds.feedblitz.com/~/742648145/0/sourcewiremedicalandpharmaceutical~Healthcare-recruitment-woes-continue/ https://www.responsesource.com/news/104072/healthcare-recruitment-woes-continue/       ]]>
The data, provided by the world’s largest network of job boards, Broadbean Technology, revealed that both job vacancies and application numbers continued to fall in April when compared to the same point last year.

The number of vacancies recorded in April 2023 was the lowest reported at any point in the past 16 months, marking an 18% decline from month-on-month. In addition, application numbers have also dropped significantly, with the figures recorded in April 2023 down 53% on March’s numbers.

The data highlights that, despite well-publicised strike action, talent shortages for nurses, carers and other medical staff persist, which will be of concern to NHS hospitals and trusts that are still in dire need of specialist healthcare professionals.

Ann Swain, Global CEO at APSCo, said

“The data shows that the continued strike action is influencing both recruitment and applications in the healthcare sector. With ongoing disputes and a fall in applications as unrest continues, hospitals and Trusts are facing significant resourcing difficulties that are showing no signs of easing. While there has been some movement in pay negotiations, the damage to the healthcare labour market that has already been done will be difficult to reverse, suggesting that struggles will only continue in the sector.”


Press Contact
Vickie Collinge
Vickie@bluesky-pr.com
01582 790705
About APSCo
The Association of Professional Staffing Companies (APSCo) is the trade association for the professional recruitment market. APSCo Global comprises APSCo Asia, APSCo Australia, APSCo Deutschland and APSCo United Kingdom as well as APSCo OutSource, the trade body for the RPO and MSP sectors.
Find out more: www.apscouk.org
      
]]> Thu, 25 May 2023 10:00:00 +0100 https://www.responsesource.com/news/104066/synapps-solutions-appoints-gary-donohue-as-nhs-account-director/ <![CDATA[SynApps Solutions appoints Gary Donohue as NHS Account Director]]> https://feeds.feedblitz.com/~/742499243/0/sourcewiremedicalandpharmaceutical~SynApps-Solutions-appoints-Gary-Donohue-as-NHS-Account-Director/ https://www.responsesource.com/news/104066/synapps-solutions-appoints-gary-donohue-as-nhs-account-director/       ]]> SynApps Solutions, the enterprise content management specialist with deep experience across the NHS, has appointed Gary Donohue as its dedicated NHS Account Director. His remit is to grow the company’s already substantial footprint within the NHS.

Donohue has a long and well-regarded career in the healthcare technology sector, including spells at Salesforce, Hyland, EMC and Fortrus, where he specialised in application user experience, content management and business process management.

“I am delighted to join SynApps Solutions, which has been helping NHS Trusts across the country to modernise everything from patient records to lung screening and radiology scans,” comments Gary Donohue, NHS Account Director, SynApps Solutions. “SynApps is a pioneer in advanced vendor-neutral archives, lung diagnostics and radiology technologies so it is an exciting time to come on board and continue to change healthcare and patient outcomes for the better.”

SynApps is transforming the way NHS Trusts provide the whole patient record including (DICOM/non-DICOM) to clinicians via existing EPR systems while sharing the records with other healthcare providers. This includes local community and potentially nationally fully supporting integrated healthcare in-line with the NHS directive for converged healthcare for NHS Trust's, ICS/ICB bodies, Mental Health, Social Care and Local Authority organisations to deliver integrated care and pathway automation.

“Gary has a wealth of healthcare technology experience going back over fifteen years so we are thrilled to welcome him to the company to help us provide even better service to our NHS clients,” adds James Paton, CEO, SynApps Solutions. “We expect Gary to be a most valuable member of the SynApps team and look forward to working together.”

About SynApps Solutions
SynApps Solutions is a widely respected independent expert in enterprise content management.
We provide highly integrated solutions and services of exceptional quality, thanks to the deep skills and experience we have amassed over the last two decades.

Our customers, which span healthcare, government and commercial markets, are able to capture, manage and share knowledge dynamically and efficiently, with proven business and regulatory compliance benefits.

We provide software, consultancy, implementation and support services for leading ECM solutions, as well as our own content integration and migration solutions, ConXApps, which allow organisations to quickly maximise their investment in ECM technologies. More at www.synapps-solutions.con

PR Contact
Carina Birt, Sarum PR – 07970 006624 or carina@sarumpr.com
      
]]> Wed, 24 May 2023 09:30:00 +0100 https://www.responsesource.com/news/104056/comprehensive-guide-to-healthcare-rights-of-patients-carers-and-practitioners/ <![CDATA[COMPREHENSIVE GUIDE TO HEALTHCARE RIGHTS OF PATIENTS, CARERS AND PRACTITIONERS]]> https://feeds.feedblitz.com/~/742082069/0/sourcewiremedicalandpharmaceutical~COMPREHENSIVE-GUIDE-TO-HEALTHCARE-RIGHTS-OF-PATIENTS-CARERS-AND-PRACTITIONERS/ https://www.responsesource.com/news/104056/comprehensive-guide-to-healthcare-rights-of-patients-carers-and-practitioners/       ]]> Healthcare Law for Patients, Carers and Practitioners

This very timely book, A Straightforward Guide to Healthcare Law for Patients, Carers and Practitioners, written against the backdrop of turbulence in the NHS, and perceived risks to patient safety, is comprehensive and easy to read, accessible to all and discusses patient rights in relation to their healthcare needs and the law that governs the delivery of healthcare and regulates healthcare practitioners. This book will be ideal for those wishing to know more about healthcare law, whether a patient, someone caring for a patient, or healthcare practitioners.

The following areas are covered in detail:
• Adult and child patients
• The role of relatives and carers
• Consent
• Confidentiality
• Accessing health records
• Decision making
• If something goes wrong

The authors:
Marc Cornock is a senior lecturer in healthcare law at The
Open University. He regularly writes and lectures on various
aspects of healthcare law.
Lindsay Giddings is a lecturer in social work at The Open
University, with a background in social work practice with
children and families.


Published 22nd May 2023, ISBN: 978-1- 80236-149-0 Price: £11.99 info@straightforwardbooks.co.uk
      
]]> Mon, 22 May 2023 12:00:00 +0100 https://www.responsesource.com/news/104052/new-research-backed-paper-warns-that-diagnosis-delay-and-symptom-disbelief/ <![CDATA[New Research-backed Paper Warns that Diagnosis Delay and Symptom Disbelief is Putting Neurodivergent Children and Young People at Greater Risk]]> https://feeds.feedblitz.com/~/742060670/0/sourcewiremedicalandpharmaceutical~New-Researchbacked-Paper-Warns-that-Diagnosis-Delay-and-Symptom-Disbelief-is-Putting-Neurodivergent-Children-and-Young-People-at-Greater-Risk/ https://www.responsesource.com/news/104052/new-research-backed-paper-warns-that-diagnosis-delay-and-symptom-disbelief/       ]]>
Lack of diagnoses and absence of the required medical help for CYP is resulting in ongoing physical health problems including but not limited to – joint pain, gastrointestinal/stomach pains, dizziness, bowel bladder issues, heart palpitations, anxiety, and extreme fatigue and tiredness. The study co-authored by Bethany Donaghy, Dr. David Moore, and Jane Green MBE, highlights three key challenges for the children and young people in schools:

--- Symptom disbelief and lack of understanding: is a common issue as medical practitioners are not trained to trace the symptoms or conditions within neurodivergent populations. As a result, children and adults are often disbelieved and this leads to further delays in diagnosis or support in education and care. This can lead to lifelong trauma for neurodivergent CYP.

--- Communication issues: including differences in interoception, meaning one’s inner sense, can be varied among neurodivergent CYP, and typically, it requires a lot of staff training to spot the symptoms of health conditions. This means the people are often misunderstood, have no other choice but to learn to ‘mask’ their pain, and do not receive help or support for these physical health problems that occur with neurodivergence more than the general neurotypical population.

--- Educational impacts: abound for neurodivergent CYP because of continuing physical health challenges due to which they end up having poorer attendance and attainment in mainstream schools as well as poorer social life with their friends/peers. This affects their mental health and wellbeing as well. Due to the mistrust or misdiagnosis in their symptoms, CYP often struggle to even get a sick note for the school from their medical practitioner due to symptomatic hypermobility being relatively unknown by medical practitioners.

The authors recommend that “all” voices of CYP should be taken into consideration for all decisions made by educational institutions and health professionals. Increasing support for attendance and attainment, updating the school environment to help manage and understand pain, providing symptomatic hypermobility training to staff, upgrading diagnostic and treatment pathways through dual-screening for hypermobility with neurodivergence, building trust with pupils, enabling support for parents/carers and looking into the need for further funded research, are some of the ways to improve the situation.

Bethany Donaghy, the author of the research paper, explains, “Within my wider research, I speak to neurodivergent children and parents regularly and unfortunately the concerns we present here are far too common. It is unfair that the neurodivergent population continue to experience such negative outcomes with their physical health experiences. We must do more as a society to address this inequality and support neurodivergent CYP now rather than continuing to do so later."

Dr. David Moore, the author of the research paper, adds, “The lack of knowledge about pain in neurodivergent populations is concerning as pain may be the first or only sign of illness or injury, and these individuals may be both at greater risk of injury as well as requiring complex care for ongoing pain. It is clear that more work is needed prevent unnecessary suffering.”

Jane Green MBE, the author of the research paper, comments, “Having gone through the personal experience of not being believed for 54 years of my life, I myself present an acute observation to the challenge of symptom-disbelief faced by our society. I didn't mask being neurodivergent, but I learnt to mask the pain associated to being symptomatic hypermobile. The paper validates that younger generation, in addition to the older generation, continue to be mistrusted about their dual condition of hypermobility and neurodivergence. Comprehensive staff training and screening for people who work in education, health and care will help us provide the opportunity, especially to the CYP, to have much healthier and fulfilled life in education, employment and social mobility.”

NOTE TO EDITORS

The paper ‘Co-Occurring Physical Health Challenges in Neurodivergent Children and Young People: A Topical Review and Recommendation’ is available here: https://www.tandfonline.com/doi/full/10.1080/13575279.2022.2.... The authors of the research paper are:

--- Bethany Donaghy: Bethany Donaghy is a PhD candidate at Liverpool John Moores University, UK. Her research looks at autistic children and young people’s experiences of pain and some of the things which may be important to these experiences. Bethany is also a pain advisor here at SEDSConnective, and first author on the Co-occurring Physical Health Challenges in Neurodivergent Children and Young People: A Topical Review and Recommendation.

--- Dr. David Moore: Dr. David Moore is a Reader in Pain Psychology at Liverpool John Moores University and a co-founder of the Somatosensory and Affective Neuroscience Research group. David’s research interests include somatosensation in autism (pain and gentle touch) as well as the cognitive impact of pain. His recent work has been seeking to examine the pain experiences and expressions of autistic people and examining how to better provide pain education and management for autistic patients. He is interested in the experiences of pain in neurodivergent people and potential links with hypermobility and is a pain adviser to the SEDSConnective charity.

--- Jane Green MBE: Jane Green MBE is Founder and Chair of SEDSConnective that is a fully user-led and voluntary charity focused on transforming health and wellbeing of neurodivergent and symptomatic hypermobility community and beyond, worldwide. She studied late and became a leading autism educationalist nationally in all phases of education. Jane is also a Non-Executive Director (NED) on four Boards ranging from education, health and social care. She is herself disabled, neurodivergent and an autistic parent carer for her eldest neurodivergent adult child. Further information on educational qualifications of the author is available here.

For media queries and to request further information on the paper, please contact:
Sonal Bisht
PR and Communications Lead
Sonal@SEDSConnective.org
+44 7528 705 069
SEDSConnective – a registered charity in England
Charity Number: 1199724
      
]]> Mon, 22 May 2023 08:00:00 +0100 https://www.responsesource.com/news/104053/international-clinical-trials-day/ <![CDATA[International Clinical Trials Day]]> https://feeds.feedblitz.com/~/741648113/0/sourcewiremedicalandpharmaceutical~International-Clinical-Trials-Day/ https://www.responsesource.com/news/104053/international-clinical-trials-day/       ]]> Celebrating advancements in Alzheimer's
20th May 2023

“Taking part in clinical research gives us hope - the breakthrough may be just around the corner - and we are at the front of the queue,” clinical trials volunteer.


It’s an exciting time for Alzheimer’s research and there have been leaps and bounds made in the development of new-generation treatments over the last few years. "Due to ongoing research and active clinical trials for Alzheimer’s, our knowledge and understanding of the disease are constantly progressing." We are closer than ever before to finding new effective treatments to diagnose the disease, treat symptoms, stop progression and eventually provide a cure.

Success has been reported recently with new generation medications Lecanemab and Donanemab, both of which have been demonstrated, in phase 3 international clinical trials, to slow progression of Alzheimer’s disease and its symptoms.

Clinical trials advance medical knowledge –regarding the safety and efficacy of new treatments, drugs, devices and interventions. This information enables researchers to better understand how diseases develop, progress and respond to treatment.

Clinical trials give people access to the latest cutting-edge treatments not available on the market. This can be particularly valuable for those who have exhausted treatment options or for those where treatment is not available, such as Alzheimer’s.


The Benefits of Clinical Trials:
• Accurate diagnosis with the most advanced diagnostic tools or biomarkers
• The chance for disease modification to SLOW/STOP progression
• Opportunity to get early access to new generation drugs that will not be available for 4-5 years, whilst the disease continues to progress
• Proactively taking control of your health & future
• The chance to avoid lengthy NHS waiting lists and access specialist private healthcare
• Regular health monitoring received with continuity of care by an expert medical team
• Outstanding medical care is provided at no cost, including comprehensive health screens, MRI scans and PET scans
• Free to participate with expenses reimbursed
• Contributing to vital research, helping to develop medications for future generations

Vicky Eyre, UK Director of Clinical Trials at Re:Cognition Health comments, “Our work in Alzheimer’s is really important; we are delighted to have conducted the recent successful studies with the Lecanemab and Donanemab, and many more new medications. Participating in a clinical trial enables volunteers to take an active role in vital research as well as their own future and they may even be part of the biggest pharmaceutical advances of our time.”

There are many ongoing clinical trials and Re:Cognition Health is actively enrolling participants for Mild Cognitive Impairment and Alzheimer’s aged 55 and over. There are also new trial opportunities in the pipeline for healthy volunteers who may be worried or have a known increased risk of developing Alzheimer’s. Studies are also available for individuals with Parkinson’s Disease, Multiple sclerosis, migraine and Long Covid.

Of course, with any disease, an early diagnosis is essential to access to new-generation medications. It’s important to be aware of the early symptoms and consult with a medical expert at the earliest opportunity.

For further information about clinical trials visit www.recognitionhealth.com

For interviews and further press information please contact: alina@alinawallace.com 07946 189672

About Re:Cognition Health:
Re:Cognition Health is a pioneering brain and mind clinic specialising in the diagnosis, treatment and care of people showing symptoms of cognitive impairment or mental health concerns. Clinical services include traumatic brain injury, neurology, children’s neurological conditions, Alzheimer’s and dementia, mental health, Long Covid. The Re:Cognition Health Clinics in Birmingham, Bristol, London, Surrey, Plymouth, Winchester, UK and Washington DC and Houston are major centres for international trials of disease-modifying and new symptomatic drugs for Alzheimer’s disease and other neurological conditions. Re:Cognition Health’s international multi-disciplinary team work collaboratively to provide a full-service, patient-centred approach using the latest progressive medical research and evidence-based treatments.
      
]]> Fri, 19 May 2023 11:00:00 +0100